Abstract
Ischaemia–reperfusion injury (IRI) during various surgical procedures, including partial nephrectomy for kidney cancer or renal transplantation, is a major cause of acute kidney injury and chronic kidney disease. Currently there are no drugs or methods for protecting human organs, including the kidneys, against the peril of IRI. The aim of this study was therefore to investigate the reno-protective effect of Zn2+ preconditioning in a clinically relevant large animal sheep model of IRI. Further the reno-protective effectiveness of Zn2+ preconditioning was tested on normal human kidney cell lines HK-2 and HEK293. Anaesthetised sheep were subjected to uninephrectomy and 60 min of renal ischaemia followed by reperfusion. Sheep were preconditioned with intravenous injection of zinc chloride prior to occlusion. Serum creatinine and urea were measured before ischaemia and for 7 days after reperfusion. HK-2 and HEK293 cells were subjected to in vitro IRI using the oxygen- and glucose-deprivation model. Zn2+ preconditioning reduced ischaemic burden determined by creatinine and urea rise over time by ~ 70% in sheep. Zn2+ preconditioning also increased the survival of normal human kidney cells subjected to cellular stress such as hypoxia, hydrogen peroxide injury, and serum starvation. Overall, our protocol incorporating specific Zn2+ dosage, number of dosages (two), time of injection (24 and 4 h prior), mode of Zn2+ delivery (IV) and testing of efficacy in a rat model, a large preclinical sheep model of IRI and cells of human origin has laid the foundation for assessment of the benefit of Zn2+ preconditioning for human applications.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- IRI:
-
Ischaemia reperfusion injury
- HIF:
-
Hypoxia inducible factor
- IC:
-
Intermittent clamping
References
Ambros JT, Herrero-Fresneda I, Borau OG, Boira JM (2007) Ischemic preconditioning in solid organ transplantation: from experimental to clinics. Transpl Int 20:219–229
Becker GJ, Hewitson TD (2013) Animal models of chronic kidney disease: useful but not perfect. Nephrol Dial Transplant 28:2432–2438. https://doi.org/10.1093/ndt/gft071
Chang M, Xiao L, Shulkes A, Baldwin GS, Patel O (2016) Zinc ions mediate gastrin expression, proliferation, and migration downstream of the cholecystokinin-2 receptor. Endocrinology 157:4706–4719. https://doi.org/10.1210/en.2016-1270
Chanoit G et al (2008) Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3beta. Am J Physiol Heart Circ Physiol 295:H1227–H1233. https://doi.org/10.1152/ajpheart.00610.2008
Chatterjee PK (2007) Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 376:1–43
Chawla LS, Eggers PW, Star RA, Kimmel PL (2014) Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371:58–66
Chowanadisai W, Graham DM, Keen CL, Rucker RB, Messerli MA (2013) Neurulation and neurite extension require the zinc transporter ZIP12 (slc39a12). Proc Natl Acad Sci USA 110:9903–9908. https://doi.org/10.1073/pnas.1222142110
Cvijanovich NZ, King JC, Flori HR, Gildengorin G, Vinks AA, Wong HR (2016) Safety and dose escalation study of intravenous zinc supplementation in pediatric critical illness. J Parenter Enter Nutr 40:860–868. https://doi.org/10.1177/0148607115572193
Dirksen MT, Laarman GJ, Simoons ML, Duncker DJ (2007) Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies. Cardiovasc Res 74:343–355
Downey JM, Cohen MV (2009) Why do we still not have cardioprotective drugs? Circ J 73:1171–1177
Duke GJ (1999) Renal protective agents: a review. Crit Care Resusc 1:265–275
Duncan A, Gallacher G, Willox L (2016) The role of the clinical biochemist in detection of zinc-induced copper deficiency. Ann Clin Biochem 53:298–301. https://doi.org/10.1177/0004563215595429
Durlach J, Guiet-Bara A, Pages N, Bac P, Bara M (2005) Magnesium chloride or magnesium sulfate: a genuine question. Magnes Res 18:187–192
Fliss H (2002) Zinc ionophores as anti-apoptotic agents. US Patent US 6407090 B1
Galasso SL, Dyck RH (2007) The role of zinc in cerebral ischemia. Mol Med 13:380–387
Guo L et al (2014) Protective effect of zinc on mouse renal ischemia-reperfusion injury by anti-apoptosis and antioxidation. Curr Pharm Biotechnol 15:577–582
Hausenloy DJ et al (2010) Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations. Basic Res Cardiol 105:677–686
Hegenauer J, Saltman P, Fairchild R, Halasz NA (1991) Improved function of reperfused rabbit kidney following administration of zinc histidine. J Trace Elem Exp Med 4:103–108
Hempe JM, Carlson JM, Cousins RJ (1991) Intestinal metallothionein gene expression and zinc absorption in rats are zinc-responsive but refractory to dexamethasone and interleukin 1 alpha. J Nutr 121:1389–1396
Jacques F et al (2012) Acute renal failure following lung transplantation: risk factors, mortality, and long-term consequences. Eur J Cardiothorac Surg 41:193–199. https://doi.org/10.1016/j.ejcts.2011.04.034
Jasim S, Tjalve H (1986) Effects of sodium pyridinethione on the uptake and distribution of nickel, cadmium and zinc in pregnant and non-pregnant mice. Toxicology 38:327–350
Karagulova G, Yue Y, Moreyra A, Boutjdir M, Korichneva I (2007) Protective role of intracellular zinc in myocardial ischemia/reperfusion is associated with preservation of protein kinase C isoforms. J Pharmacol Exp Ther 321:517–525
Kasi V, Bodiga S, Kommuguri UN, Sankuru S, Bodiga VL (2011) Zinc pyrithione salvages reperfusion injury by inhibiting NADPH oxidase activation in cardiomyocytes. Biochem Biophys Res Commun 410:270–275. https://doi.org/10.1016/j.bbrc.2011.05.130
Kulkarni GV, McCulloch CA (1994) Serum deprivation induces apoptotic cell death in a subset of Balb/c 3T3 fibroblasts. J Cell Sci 107:1169–1179
Law W, Kelland EE, Sharp P, Toms NJ (2003) Characterisation of zinc uptake into rat cultured cerebrocortical oligodendrocyte progenitor cells. Neurosci Lett 352:113–116
Lee JY, Kim YJ, Kim TY, Koh JY, Kim YH (2008) Essential role for zinc-triggered p75NTR activation in preconditioning neuroprotection. J Neurosci 28:10919–10927
Lee S, Chanoit G, McIntosh R, Zvara DA, Xu Z (2009) Molecular mechanism underlying Akt activation in zinc-induced cardioprotection. Am J Physiol Heart Circ Physiol 297:H569–H575
Malek M, Nematbakhsh M (2015) Renal ischemia/reperfusion injury; from pathophysiology to treatment. J Renal Injury Prev 4:20–27
Marshall KM et al (2015) Activation by zinc of the human gastrin gene promoter in colon cancer cells in vitro and in vivo. Metallomics 7:1390–1398
Matsushita K et al (1996) Effect of systemic zinc administration on delayed neuronal death in the gerbil hippocampus. Brain Res 743:362–365
Ogawa T, Mimura Y (1999) Antioxidant effect of zinc on acute renal failure induced by ischemia-reperfusion injury in rats. Am J Nephrol 19:609–614
Powell SR, Aiuto L, Hall D, Tortolani AJ (1995) Zinc supplementation enhances the effectiveness of St. Thomas’ Hospital No. 2 cardioplegic solution in an in vitro model of hypothermic cardiac arrest. J Thorac Cardiovasc Surg 110:1642–1648. https://doi.org/10.1016/S0022-5223(95)70025-0
Powell SR, Nelson RL, Finnerty J, Alexander D, Pottanat G, Kooker K, Schiff RJ, Moyse J, Teichberg S, Tortolani AJ (1997) Zinc-bis-histidinate preserves cardiac function in a porcine model of cardioplegic arrest. Ann Thorac Surg 64:73–80
Rao K et al (2017) Protective effect of zinc preconditioning against renal ischemia reperfusion injury is dose dependent. PLoS ONE 12:e0180028. https://doi.org/10.1371/journal.pone.0180028
Rizvi M, Jawad N, Li Y, Vizcaychipi MP, Maze M, Ma D (2010) Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells. Exp Biol Med (Maywood) 235:886–891. https://doi.org/10.1258/ebm.2010.009366
Rudolf E, Cervinka M (2010) Zinc pyrithione induces cellular stress signaling and apoptosis in Hep-2 cervical tumor cells: the role of mitochondria and lysosomes. Biometals 23:339–354. https://doi.org/10.1007/s10534-010-9302-8
Russ AL, Haberstroh KM, Rundell AE (2007) Experimental strategies to improve in vitro models of renal ischemia. Exp Mol Pathol 83:143–159. https://doi.org/10.1016/j.yexmp.2007.03.002
Saver JL et al (2015) Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med 372:528–536. https://doi.org/10.1056/NEJMoa1408827
Schanz M, Schaaf L, Dippon J, Biegger D, Fritz P, Alscher MD, Kimmel M (2017) Renal effects of metallothionein induction by zinc in vitro and in vivo. BMC Nephrol 18:91. https://doi.org/10.1186/s12882-017-0503-z
Scholmerich J et al (1987) Bioavailability of zinc from zinc–histidine complexes. I. Comparison with zinc sulfate in healthy men. Am J Clin Nutr 45:1480–1486
Serra-Perez A, Planas AM, Nunez-O’Mara A, Berra E, Garcia-Villoria J, Ribes A, Santalucia T (2010) Extended ischemia prevents HIF1alpha degradation at reoxygenation by impairing prolyl-hydroxylation: role of Krebs cycle metabolites. J Biol Chem 285:18217–18224. https://doi.org/10.1074/jbc.M110.101048
Sobieszczanska M, Tubek S, Szygula R, Bunio A (2012) Is the zinc neuroprotective effect caused by prevention of intracellular zinc accumulation? Adv Clin Exp Med 21:245–248
Talan MI, Ahmet I, Lakatta EG (2012) Did clinical trials in which erythropoietin failed to reduce acute myocardial infarct size miss a narrow therapeutic window? PLoS ONE 7:e34819. https://doi.org/10.1371/journal.pone.0034819
Turer AT, Hill JA (2010) Pathogenesis of myocardial ischemia–reperfusion injury and rationale for therapy. Am J Cardiol 106:360–368
Veighey K, MacAllister R (2015) Clinical applications of remote ischaemic preconditioning in native and transplant acute kidney injury. Pediatr Nephrol 30:1749–1759
Viswanath K, Bodiga S, Balogun V, Zhang A, Bodiga VL (2011) Cardioprotective effect of zinc requires ErbB2 and Akt during hypoxia/reoxygenation. Biometals 24:171–180
Xiao L, Kovac S, Chang M, Shulkes A, Baldwin GS, Patel O (2014) Zinc ions upregulate the hormone gastrin via an E-box motif in the proximal gastrin promoter. J Mol Endocrinol 52:29–42
Xu Z, Zhou J (2013) Zinc and myocardial ischemia/reperfusion injury. Biometals 26:863–878
Yoshida T et al (2008) ATF3 protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 19:217–224. https://doi.org/10.1681/ASN.2005111155
Zackular JP et al (2016) Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection. Nat Med 22:1330–1334. https://doi.org/10.1038/nm.4174
Zarjou A, Sanders PW, Mehta RL, Agarwal A (2012) Enabling innovative translational research in acute kidney injury. Clin Transl Sci 5:93–101
Zhang L, Diao Y, Chen G, Tanaka A, Eastwood GM, Bellomo R (2016) Remote ischemic conditioning for kidney protection: a meta-analysis. J Crit Care 33:224–232. https://doi.org/10.1016/j.jcrc.2016.01.026
Acknowledgements
This work was in part supported by the Austin Health Medical Research Foundation and by University of Melbourne.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors JI, DB, AS, GSB and OP have filed a patent on some of the work described here.
Rights and permissions
About this article
Cite this article
O’Kane, D., Gibson, L., May, C.N. et al. Zinc preconditioning protects against renal ischaemia reperfusion injury in a preclinical sheep large animal model. Biometals 31, 821–834 (2018). https://doi.org/10.1007/s10534-018-0125-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-018-0125-3